Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Sheila Singh"'
Autor:
Solsa Cariba, Cole Nickason, Mikhail Salnikov, Fuad Chowdhury, Kabir Siraj, Vanshika Khaitan, Connor Clark-Baba, Alberto Torrez, Sheila Singh, Hong Han
Publikováno v:
Genetics in Medicine Open, Vol 2, Iss , Pp 100983- (2024)
Externí odkaz:
https://doaj.org/article/f11e173e5cc248ffac7222a9d36912f4
Autor:
Kevin Brown, Sheila Singh, Hong Han, Mathieu Seyfrid, William Thomas Maich, Vaseem Muhammad Shaikh, Nazanin Tatari, Deepak Upreti, Deween Piyasena, Minomi Subapanditha, Neil Savage, Dillon McKenna, Nicholas Mikolajewicz, Chirayu Chokshi, Laura Kuhlmann, Amanda Khoo, Sabra Khalid Salim, Blessing Archibong-Bassey, William Gwynne, Nadeem Murtaza, David Bakhshinyan, Parvez Vora, Chitra Venugopal, Jason Moffat, Thomas Kislinger
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/58fa9edb89474cc79d6aba282cfc533f
Publikováno v:
STAR Protocols, Vol 2, Iss 4, Pp 100920- (2021)
Summary: Advances in chimeric antigen receptor (CAR) T cell therapies have led to the modality dominating translational cancer research; however, a standardized protocol for evaluating such therapies in vitro is needed. This protocol details the in v
Externí odkaz:
https://doaj.org/article/ef405b1b714549da8142d2fdec868794
Autor:
Nazanin Tatari, William T. Maich, Sabra K. Salim, Dillon Mckenna, Chitra Venugopal, Sheila Singh
Publikováno v:
STAR Protocols, Vol 1, Iss 3, Pp 100174- (2020)
Summary: Glioblastoma (GBM) is the most common malignant adult brain tumor that is resistant to the standard care therapy. Advances in chimeric antigen receptor (CAR) T cell therapies have spurred renewed interest in developing CAR T cell therapies t
Externí odkaz:
https://doaj.org/article/915efde6842243eb88b230ca0e0e28fc
Publikováno v:
Child's Nervous System. 39:887-894
Autor:
Neil Savage, Franz Zemp, Nick Mikolajewicz, Hong Han, Chitra Venugopal, Chirayu Chokshi, Nazanin Tatari, Thomas Kislinger, Jason Moffat, Doug Mahoney, Sheila Singh
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Sheila Singh, Chirayu Chokshi, David Tieu, Kevin Brown, Chitra Venugopal, Martin Rossotti, Katherine Chan, Amy Tong, Laura Kuhlmann, Lina Liu, Benjamin Brakel, Vaseem Shaikh, William Maich, Yujin Suk, Daniel Mobilio, Neil Savage, Nikoo Aghaei, Minomi Subapanditha, Dillon McKenna, Vladimir Ignatchenko, Joseph Salamoun, Peter Wipf, Elizabeth Sharlow, John Provias, Jian-Qiang Lu, Naresh Murty, John Lazo, Thomas Kislinger, Kevin Henry, Yu Lu, Jason Moffat
Resistance to genotoxic therapies and tumor recurrence are hallmarks of glioblastoma (GBM), an aggressive brain tumor. Here, we explore the functional drivers of post-treatment recurrent GBM. By conducting genome-wide CRISPR-Cas9 screens in patient-d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::934ca2c72f06c0fdd3cbf32e27e60300
https://doi.org/10.21203/rs.3.rs-1871890/v1
https://doi.org/10.21203/rs.3.rs-1871890/v1
Autor:
Zsolt Zador, Nicholas Mikolajewicz, Hong Han, Mathew Voisin, Chitra Venugopal, Chirayu Chokshi, Will Maich, Moffat Jason, Gelareh Zadeh, Sheila Singh
Publikováno v:
Neuro-Oncology. 24:vii291-vii292
Persister states are proposed oncogenic substrates of disease recurrence in cancer. Recent concepts suggest persisters may occur in dynamic states of the cell cycle (such as cycling and non-cycling states). We therefore investigated biological progra
Autor:
Agata Kieliszek, Daniel Mobilio, Blessing Bassey-Archibong, Jarrod Johnson, Chitra Venugopal, Jakob Magolan, Sheila Singh
Publikováno v:
Neuro-Oncology. 24:vii98-vii99
The current standard of care for (surgery and radiation) for brain metastases (BM) is inadequate as BM have a 90% mortality rate within one year of diagnosis, posing a large unmet clinical need. The Singh lab has generated a large in-house biobank of
Autor:
Kevin Wyszatko, Luis Rafael Silva, Teesha Komal, Luke Yongkyu Kwon, Manuela Ventura, Sheila Singh, John Valliant, Saman Sadeghi
Publikováno v:
Nuclear Medicine and Biology. :S19-S20